[{"Assets_0_FY_USD":2342631000.0,"CommonStockSharesOutstanding_0_FY_shares":48028413.0,"EarningsPerShareBasic_4_FY_USD":-1.29,"EarningsPerShareDiluted_1_FY_USD":-0.61,"EarningsPerShareDiluted_4_FY_USD":-1.29,"NetCashProvidedByUsedInOperatingActivities_4_FY_USD":90151000.0,"NetIncomeLoss_1_FY_USD":-29799000.0,"NetIncomeLoss_4_FY_USD":-62789000.0,"StockholdersEquity_0_FY_USD":1706909000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":48860352.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":48860352.0,"Ticker":"LIVN","CIK":"1639691","name":"LIVANOVA PLC","OfficialName":"LivaNova PLC Ordinary Shares","form":"10-K","period":"20161231","fy":"2016.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"4559360993.0","Country":"United Kingdom","Sector":"Health Care","Industry":"Biotechnology: Electromedical & Electrotherapeutic Apparatus","Market":"NASDAQ","SP500":"nan","filed":"20170301"}]